Delivery Order SPE2DB22D2211-SPE2DB25FRTYG
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,501.07, is for the delivery of 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a period of performance through June 12, 2024 and is a Firm Fixed Price Delivery Order. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,517.71 firm fixed-price delivery order is for 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. This award appears to be part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,615.46 firm fixed-price delivery order is for the supply of 120 tablets of 1.2 gram Mesalamine delayed-release tablets, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,061.39 contract is for the delivery of 120-count tablets of the drug mesalamine 1.2 grams, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of October 2, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat conditions such as ulcerative colitis. The award has a ceiling value of $1,184.05 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 28, 2025. The contract is not designated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,130.82 delivery order contract is for the supply of 120 tablets of Mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a firm fixed price and runs through May 5, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,726.18 fixed-price delivery order is for the supply of 180 count bottles of 800 mg delayed-release mesalamine tablets, a medication used to treat ulcerative colitis. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,170.87, is for the delivery of 4,563,198,346 units of Mesalamine 800 mg delayed-release tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides Mesalamine delayed-release 1.2 gram tablets for a ceiling value of $10,635.52. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999 through December 2025, for...
This federal contract award, valued at $4,964.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,681,620 units of Mesalamine 800 mg delayed-release tablets, a medication used to treat certain inflammatory bowel conditions. The contract has an ultimate completion date of May 23, 2024 and is structured as a Firm Fixed Price Delivery Order. This award...